Abstract:e21055 Background: While methods for detecting SNV and indel in circulating tumor DNA (ctDNA) with hybrid-capture based next generation sequencing (NGS) has been available, algorithm for calling copy number variation(CNV) is more challenging. Here we present a method enabling CNV detection in very low amount of ctDNA with high sensitivity and specificity. Methods: First of all, we built a background model with a customized 150 gene panel cfDNA sequencing data from 10 healthy people. This model was then applied to normalize read depth to further reduce background noise. The probe level log2ratio was segmented using circular binary segmentation. Segments with log2ratio above 3 fold standard deviation was treated as amplification. Then we used NCI-H1573 and HCC1954 cell culture supernatant, which harbored three CNVs: ERBB2 (HCC1954), EGFR and MET (NCI-H1573), to mimic human ctDNA. Both in-silicon and in-vitro simulations were performed to define the detection limit. We validated the CNV concordance of FFPE samples and matched controls with WES profiling and plasma samples with 150 gene panel profiling from 28 lung cancer patients. Additional 1495 ctDNA samples were also profiled with 150 gene panel. Results: For in-silicon spike-in, the detection limit of ctDNA fraction is about 0.3% for ERBB2 (2.2 copy), 5% for MET (2.5 copy), 1% for EGFR (2.2 copy). For in-vitro spike-in, the detection limit of ctDNA fraction is about 1% for ERBB2 (2.6 copy), 5% for MET (2.5 copy), 3% for EGFR (2.6 copy). Compared with WES CNV results, the specificity of CNV calling from ctDNA panel is 95.5% and sensitivity is 50% when copy number > 6, and 71.4% when copy number > 12. We profiled 1495 lung cancer ctDNA samples with 150 gene panel and detected 15 HER2 amplification(1%), 75 EGFR amplification(5%) and 30 MET amplification samples(2%). An advanced lung adenocarcinoma patient with acquired resistance after EGFR TKI treatment, MET amplification was detected in plasma ctDNA. Patient accepted crizotinib and reached partial response. Conclusions: We developed a pipeline to detect CNV in very low amount of ctDNA with high sensitivity and specificity, which improves the accuracy of CNV calling in noninvasive way and avoids unnecessary biopsy on tumor patients.

Joint Detection of Germline and Somatic Copy Number Events in Matched Tumor-Normal Sample Pairs.

Accuracy Of Cnv Detection From Gwas Data

A CNV Computational Model for Clonal Origin Analysis of Synchronous Multifocal Hepatobiliary and Pancreatic Tumors.

SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.

Copy Number Analysis Of Whole-Genome Data Using Bic-Seq2 And Its Application To Detection Of Cancer Susceptibility Variants

Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome

A Single Cell Level Based Method For Copy Number Variation Analysis By Low Coverage Massively Parallel Sequencing

Technical And Clinical Validation Of Somatic Cnv Detection From Circulating Tumor Dna.

A clinically feasible algorithm for the parallel detection of glioma-associated copy number variation markers based on shallow whole genome sequencing

Comprehensive Assessment of Somatic Copy Number Variation Calling Using Next-Generation Sequencing Data

Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.

Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples

SCONCE: a method for profiling copy number alterations in cancer evolution using single-cell whole genome sequencing

Cnv Detection From Circulating Tumor Dna In Late Stage Non-Small Cell Lung Cancer Patients

DL-CNV: A Deep Learning Method for Identifying Copy Number Variations Based on Next Generation Target Sequencing

BagGMM: Calling Copy Number Variation by Bagging Multiple Gaussian Mixture Models from Tumor and Matched Normal Next-Generation Sequencing Data

Joint detection of copy number variations in parent-offspring trios.

Clonecna: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

Benchmarking of Germline Copy Number Variant Callers from Whole Genome Sequencing Data for Clinical Applications

JAX-CNV: A Whole Genome Sequencing-Based Algorithm for Copy Number Detection at Clinical Grade Level

Discrimination of Recurrent CNVs from Individual Ones from Multisample Acgh by Jointly Constrained Minimization